Healthcare provider profile · identity verified

Robert T. Tompkins, M.D.

Internal Medicine · LONGVIEW, TX · NPI 1922165661

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	357	78
Amlodipine Besylate	Amlodipine Besylate	343	97
Atorvastatin Calcium	Atorvastatin Calcium	341	89
Lisinopril	Lisinopril	273	70
Metformin Hcl	Metformin Hcl	244	72
Omeprazole	Omeprazole	201	57
Pantoprazole Sodium	Pantoprazole Sodium	195	52
Alprazolam	Alprazolam	194	27
Gabapentin	Gabapentin	152	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	149	15
Metoprolol Succinate	Metoprolol Succinate	148	43
Tamsulosin Hcl	Tamsulosin Hcl	140	36
Losartan Potassium	Losartan Potassium	130	46
Zolpidem Tartrate	Zolpidem Tartrate	124	19
Simvastatin	Simvastatin	122	33
Glimepiride	Glimepiride	121	33
Albuterol Sulfate Hfa	Albuterol Sulfate	115	37
Trazodone Hcl	Trazodone Hcl	115	26
Metoprolol Tartrate	Metoprolol Tartrate	111	34
Pravastatin Sodium	Pravastatin Sodium	111	36
Hydrochlorothiazide	Hydrochlorothiazide	106	36
Allopurinol	Allopurinol	100	20
Meloxicam	Meloxicam	99	31
Montelukast Sodium	Montelukast Sodium	99	23
Fluticasone Propionate	Fluticasone Propionate	95	17
Furosemide	Furosemide	95	30
Potassium Chloride	Potassium Chloride	94	29
Clonazepam	Clonazepam	92	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	24
Sertraline Hcl	Sertraline Hcl	86	26
Azithromycin	Azithromycin	81	66
Rosuvastatin Calcium	Rosuvastatin Calcium	81	30
Clopidogrel	Clopidogrel Bisulfate	74	22
Duloxetine Hcl	Duloxetine Hcl	71	24
Pregabalin	Pregabalin	69	12
Tramadol Hcl	Tramadol Hcl	69	21
Metformin Hcl Er	Metformin Hcl	67	16
Acetaminophen-Codeine	Acetaminophen With Codeine	66	19
Carvedilol	Carvedilol	63	20
Ozempic	Semaglutide	63	15
Famotidine	Famotidine	61	15
Irbesartan	Irbesartan	56	16
Lorazepam	Lorazepam	54	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	52	13
Quetiapine Fumarate	Quetiapine Fumarate	52	13
Fluoxetine Hcl	Fluoxetine Hcl	47	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	11
Tizanidine Hcl	Tizanidine Hcl	46	suppressed
Olanzapine	Olanzapine	45	suppressed
Donepezil Hcl	Donepezil Hcl	40	suppressed
Mirtazapine	Mirtazapine	40	13
Prednisone	Prednisone	40	29
Temazepam	Temazepam	40	suppressed
Celecoxib	Celecoxib	38	15
Atenolol	Atenolol	37	12
Pioglitazone Hcl	Pioglitazone Hcl	37	12
Lovastatin	Lovastatin	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	35	suppressed
Ondansetron Odt	Ondansetron	34	suppressed
Azelastine Hcl	Azelastine Hcl	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Oxcarbazepine	Oxcarbazepine	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	24
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Baclofen	Baclofen	29	suppressed
Finasteride	Finasteride	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Eliquis	Apixaban	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	19
Telmisartan	Telmisartan	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Diazepam	Diazepam	26	suppressed
Estradiol	Estradiol	26	suppressed
Gemfibrozil	Gemfibrozil	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	11
Warfarin Sodium	Warfarin Sodium	26	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Glipizide	Glipizide	25	suppressed
Mounjaro	Tirzepatide	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Valsartan	Valsartan	22	suppressed
Asenapine Maleate	Asenapine Maleate	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Risperidone	Risperidone	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Glycopyrrolate	Glycopyrrolate	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Methylprednisolone	Methylprednisolone	16	14
Novolog Flexpen	Insulin Aspart	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Fluconazole	Fluconazole	15	11
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Topiramate	Topiramate	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	13	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Cephalexin	Cephalexin	12	12
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Prempro	Estrogen,con/M-Progest Acet	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Torsemide	Torsemide	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Fluocinolone Acetonide	Fluocinolone Acetonide	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Nadolol	Nadolol	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error